BIO-key International, Inc.
BKYI
$0.8548
$0.03484.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -26.32% | -19.88% | 18.03% | -40.83% | -0.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -26.32% | -19.88% | 18.03% | -40.83% | -0.12% |
| Cost of Revenue | -6.71% | -86.34% | -68.50% | -83.67% | -77.31% |
| Gross Profit | -29.44% | 1,356.44% | 393.30% | 172.30% | 117.90% |
| SG&A Expenses | -23.02% | -14.90% | -9.48% | -9.39% | -7.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.44% | -39.99% | -27.96% | -35.10% | -31.76% |
| Operating Income | -25.88% | 53.46% | 70.47% | 30.46% | 71.06% |
| Income Before Tax | -44.33% | 46.88% | 59.79% | 32.78% | 69.77% |
| Income Tax Expenses | -- | 91.69% | -- | -- | -- |
| Earnings from Continuing Operations | -44.33% | 41.65% | 59.79% | 36.44% | 69.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.33% | 41.65% | 59.79% | 36.44% | 69.77% |
| EBIT | -25.88% | 53.46% | 70.47% | 30.46% | 71.06% |
| EBITDA | -33.28% | 54.04% | 74.71% | 31.97% | 75.53% |
| EPS Basic | 50.43% | 89.77% | 87.86% | 78.72% | 91.00% |
| Normalized Basic EPS | 50.41% | 91.19% | 88.87% | 77.08% | 91.70% |
| EPS Diluted | 50.43% | 89.77% | 87.86% | 78.72% | 91.00% |
| Normalized Diluted EPS | 50.41% | 91.19% | 88.87% | 77.08% | 91.70% |
| Average Basic Shares Outstanding | 191.12% | 470.50% | 231.06% | 198.67% | 235.96% |
| Average Diluted Shares Outstanding | 191.12% | 470.50% | 231.06% | 198.67% | 235.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |